annual total liabilities:
$64.44B+$11.30B(+21.26%)Summary
- As of today (April 15, 2025), LLY annual total liabilities is $64.44 billion, with the most recent change of +$11.30 billion (+21.26%) on December 31, 2024.
- During the last 3 years, LLY annual total liabilities has risen by +$24.79 billion (+62.53%).
- LLY annual total liabilities is now at all-time high.
Performance
LLY Total liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly total liabilities:
$64.44B+$3.16B(+5.15%)Summary
- As of today (April 15, 2025), LLY quarterly total liabilities is $64.44 billion, with the most recent change of +$3.16 billion (+5.15%) on December 31, 2024.
- Over the past year, LLY quarterly total liabilities has increased by +$11.30 billion (+21.26%).
- LLY quarterly total liabilities is now at all-time high.
Performance
LLY quarterly total liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Total liabilities Formula
Total Liabilities = Current Liabilities + Long-Term Liabilities
LLY Total liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +21.3% | +21.3% |
| 3 y3 years | +62.5% | +53.9% |
| 5 y5 years | +76.1% | +53.9% |
LLY Total liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +66.5% | at high | +72.8% |
| 5 y | 5-year | at high | +76.1% | at high | +72.8% |
| alltime | all time | at high | +4429.6% | at high | +4429.6% |
Eli Lilly and Company Total liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $64.44B(+21.3%) | $64.44B(+5.2%) |
| Sep 2024 | - | $61.29B(+5.2%) |
| Jun 2024 | - | $58.24B(+14.1%) |
| Mar 2024 | - | $51.05B(-3.9%) |
| Dec 2023 | $53.14B(+37.3%) | $53.14B(+14.0%) |
| Sep 2023 | - | $46.61B(+6.7%) |
| Jun 2023 | - | $43.66B(+4.3%) |
| Mar 2023 | - | $41.87B(+8.1%) |
| Dec 2022 | $38.71B(-2.4%) | $38.71B(+3.8%) |
| Sep 2022 | - | $37.30B(-2.9%) |
| Jun 2022 | - | $38.40B(+2.5%) |
| Mar 2022 | - | $37.46B(-5.5%) |
| Dec 2021 | $39.65B(-2.8%) | $39.65B(-1.4%) |
| Sep 2021 | - | $40.23B(-2.2%) |
| Jun 2021 | - | $41.15B(+3.5%) |
| Mar 2021 | - | $39.74B(-2.6%) |
| Dec 2020 | $40.81B(+11.5%) | $40.81B(+4.8%) |
| Sep 2020 | - | $38.95B(+3.3%) |
| Jun 2020 | - | $37.70B(-0.6%) |
| Mar 2020 | - | $37.91B(+3.6%) |
| Dec 2019 | $36.59B(+10.9%) | $36.59B(+6.3%) |
| Sep 2019 | - | $34.43B(-3.8%) |
| Jun 2019 | - | $35.81B(+1.0%) |
| Mar 2019 | - | $35.44B(+7.4%) |
| Dec 2018 | $33.00B(-0.9%) | $33.00B(+8.3%) |
| Sep 2018 | - | $30.47B(-0.9%) |
| Jun 2018 | - | $30.74B(+3.3%) |
| Mar 2018 | - | $29.77B(-10.6%) |
| Dec 2017 | $33.31B(+34.7%) | $33.31B(+18.8%) |
| Sep 2017 | - | $28.05B(+4.8%) |
| Jun 2017 | - | $26.78B(+13.8%) |
| Mar 2017 | - | $23.52B(-4.9%) |
| Dec 2016 | $24.73B(+17.9%) | $24.73B(+12.5%) |
| Sep 2016 | - | $21.97B(+0.7%) |
| Jun 2016 | - | $21.82B(+11.0%) |
| Mar 2016 | - | $19.66B(-6.3%) |
| Dec 2015 | $20.98B(+0.3%) | $20.98B(-0.4%) |
| Sep 2015 | - | $21.06B(-1.3%) |
| Jun 2015 | - | $21.33B(+3.0%) |
| Mar 2015 | - | $20.71B(-1.0%) |
| Dec 2014 | $20.92B(+18.8%) | $20.92B(+23.3%) |
| Sep 2014 | - | $16.97B(-0.3%) |
| Jun 2014 | - | $17.02B(+3.8%) |
| Mar 2014 | - | $16.41B(-6.8%) |
| Dec 2013 | $17.61B(-10.3%) | $17.61B(+3.2%) |
| Sep 2013 | - | $17.07B(-5.1%) |
| Jun 2013 | - | $17.99B(+3.7%) |
| Mar 2013 | - | $17.34B(-11.6%) |
| Dec 2012 | $19.63B(-2.5%) | $19.63B(+7.5%) |
| Sep 2012 | - | $18.26B(+4.3%) |
| Jun 2012 | - | $17.50B(+0.5%) |
| Mar 2012 | - | $17.42B(-13.5%) |
| Dec 2011 | $20.12B(+8.3%) | $20.12B(+11.9%) |
| Sep 2011 | - | $17.98B(-2.8%) |
| Jun 2011 | - | $18.50B(+4.2%) |
| Mar 2011 | - | $17.76B(-4.5%) |
| Dec 2010 | $18.59B(+3.6%) | $18.59B(+6.3%) |
| Jun 2010 | - | $17.49B(+4.5%) |
| Mar 2010 | - | $16.74B(-6.7%) |
| Dec 2009 | $17.94B(-20.2%) | $17.94B(+4.1%) |
| Sep 2009 | - | $17.22B(-6.3%) |
| Jun 2009 | - | $18.37B(-2.7%) |
| Mar 2009 | - | $18.87B(-16.0%) |
| Dec 2008 | $22.47B(+68.1%) | $22.47B(+60.9%) |
| Sep 2008 | - | $13.97B(+7.3%) |
| Jun 2008 | - | $13.01B(+5.7%) |
| Mar 2008 | - | $12.31B(-7.9%) |
| Dec 2007 | $13.37B(+21.8%) | $13.37B(+11.2%) |
| Sep 2007 | - | $12.03B(-3.8%) |
| Jun 2007 | - | $12.50B(+2.4%) |
| Mar 2007 | - | $12.20B(+11.2%) |
| Dec 2006 | $10.97B | $10.97B(+1.1%) |
| Sep 2006 | - | $10.86B(-13.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2006 | - | $12.51B(+0.4%) |
| Mar 2006 | - | $12.45B(-9.7%) |
| Dec 2005 | $13.79B(-1.1%) | $13.79B(+2.7%) |
| Sep 2005 | - | $13.42B(+2.0%) |
| Jun 2005 | - | $13.15B(+13.0%) |
| Mar 2005 | - | $11.64B(-16.5%) |
| Dec 2004 | $13.95B(+17.0%) | $13.95B(+8.3%) |
| Sep 2004 | - | $12.88B(+4.9%) |
| Jun 2004 | - | $12.27B(+3.6%) |
| Mar 2004 | - | $11.84B(-0.7%) |
| Dec 2003 | $11.92B(+10.7%) | $11.92B(+5.4%) |
| Sep 2003 | - | $11.32B(-0.4%) |
| Jun 2003 | - | $11.37B(+4.1%) |
| Mar 2003 | - | $10.91B(+1.4%) |
| Dec 2002 | $10.77B(+15.4%) | $10.77B(+1.0%) |
| Sep 2002 | - | $10.66B(+8.8%) |
| Jun 2002 | - | $9.80B(+4.7%) |
| Mar 2002 | - | $9.36B(+0.3%) |
| Dec 2001 | $9.33B(+7.9%) | $9.33B(+3.3%) |
| Sep 2001 | - | $9.03B(+1.8%) |
| Jun 2001 | - | $8.87B(+8.7%) |
| Mar 2001 | - | $8.16B(-5.6%) |
| Dec 2000 | $8.64B(+10.6%) | $8.64B(+14.9%) |
| Sep 2000 | - | $7.52B(+0.1%) |
| Jun 2000 | - | $7.52B(+6.8%) |
| Mar 2000 | - | $7.04B(-9.9%) |
| Dec 1999 | $7.81B(-4.3%) | $7.81B(+4.7%) |
| Sep 1999 | - | $7.46B(+17.2%) |
| Jun 1999 | - | $6.37B(+0.1%) |
| Mar 1999 | - | $6.37B(-22.0%) |
| Dec 1998 | $8.17B(+5.1%) | $8.17B(+3.2%) |
| Sep 1998 | - | $7.91B(+12.0%) |
| Jun 1998 | - | $7.07B(-0.4%) |
| Mar 1998 | - | $7.09B(-8.7%) |
| Dec 1997 | $7.77B(-5.3%) | $7.77B(+4.6%) |
| Sep 1997 | - | $7.43B(-2.5%) |
| Jun 1997 | - | $7.62B(-4.1%) |
| Mar 1997 | - | $7.94B(-3.2%) |
| Dec 1996 | $8.21B(-8.6%) | $8.21B(+2.3%) |
| Sep 1996 | - | $8.03B(-4.1%) |
| Jun 1996 | - | $8.37B(+0.6%) |
| Mar 1996 | - | $8.31B(-7.4%) |
| Dec 1995 | $8.98B(-1.9%) | $8.98B(+2.5%) |
| Sep 1995 | - | $8.77B(-3.9%) |
| Jun 1995 | - | $9.12B(-0.0%) |
| Mar 1995 | - | $9.13B(-0.3%) |
| Dec 1994 | $9.15B(+81.1%) | $9.15B(+76.2%) |
| Sep 1994 | - | $5.19B(+3.3%) |
| Jun 1994 | - | $5.03B(+3.3%) |
| Mar 1994 | - | $4.87B(-3.7%) |
| Dec 1993 | $5.05B(+33.7%) | $5.05B(+31.2%) |
| Sep 1993 | - | $3.85B(+2.9%) |
| Jun 1993 | - | $3.74B(-2.3%) |
| Mar 1993 | - | $3.83B(+1.4%) |
| Dec 1992 | $3.78B(+13.4%) | $3.78B(+2.1%) |
| Sep 1992 | - | $3.70B(+15.3%) |
| Jun 1992 | - | $3.21B(+3.1%) |
| Mar 1992 | - | $3.11B(-6.6%) |
| Dec 1991 | $3.33B(-9.3%) | $3.33B(+10.3%) |
| Sep 1991 | - | $3.02B(+11.3%) |
| Jun 1991 | - | $2.71B(+4.1%) |
| Mar 1991 | - | $2.61B(-29.1%) |
| Dec 1990 | $3.68B(+75.8%) | $3.68B(+11.9%) |
| Sep 1990 | - | $3.28B(+31.9%) |
| Jun 1990 | - | $2.49B(+24.2%) |
| Mar 1990 | - | $2.00B(-4.1%) |
| Dec 1989 | $2.09B(+2.6%) | $2.09B(+6.9%) |
| Sep 1989 | - | $1.96B(+5.6%) |
| Jun 1989 | - | $1.85B(-9.1%) |
| Dec 1988 | $2.04B(-7.9%) | $2.04B(-7.9%) |
| Dec 1987 | $2.21B(+19.2%) | $2.21B(+19.2%) |
| Dec 1986 | $1.86B(+18.5%) | $1.86B(+18.5%) |
| Dec 1985 | $1.57B(+10.1%) | $1.57B(+10.1%) |
| Dec 1984 | $1.42B | $1.42B |
FAQ
- What is Eli Lilly and Company annual total liabilities?
- What is the all time high annual total liabilities for Eli Lilly and Company?
- What is Eli Lilly and Company annual total liabilities year-on-year change?
- What is Eli Lilly and Company quarterly total liabilities?
- What is the all time high quarterly total liabilities for Eli Lilly and Company?
- What is Eli Lilly and Company quarterly total liabilities year-on-year change?
What is Eli Lilly and Company annual total liabilities?
The current annual total liabilities of LLY is $64.44B
What is the all time high annual total liabilities for Eli Lilly and Company?
Eli Lilly and Company all-time high annual total liabilities is $64.44B
What is Eli Lilly and Company annual total liabilities year-on-year change?
Over the past year, LLY annual total liabilities has changed by +$11.30B (+21.26%)
What is Eli Lilly and Company quarterly total liabilities?
The current quarterly total liabilities of LLY is $64.44B
What is the all time high quarterly total liabilities for Eli Lilly and Company?
Eli Lilly and Company all-time high quarterly total liabilities is $64.44B
What is Eli Lilly and Company quarterly total liabilities year-on-year change?
Over the past year, LLY quarterly total liabilities has changed by +$11.30B (+21.26%)